Literature DB >> 9487253

Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro.

L C Tetlow1, D E Woolley.   

Abstract

The degradation of fibrillar type II collagen is a major feature of cartilage destruction in rheumatoid arthritis (RA). Since collagenase 3 is produced by chondrocytes and preferentially degrades type II cartilage collagen, it seemed likely that this enzyme would have a prominent role in the destruction of rheumatoid joints. Using immunolocalization techniques, we have examined and compared the production and distributions of collagenase 1 and collagenase 3 in cells and tissues derived from rheumatoid knee arthroplasties. Primary cultures of chondrocytes stimulated with interleukin-1 beta showed that most of the cells produced collagenase 1, whereas only a minority (approximately 5-10%) produced collagenase 3; a few chondrocytes demonstrated the co-ordinate production of both enzymes. Primary cultures of rheumatoid synoviocytes produced collagenase 1, but not collagenase 3. Both enzymes were demonstrated in the rheumatoid lesion. Collagenase 1 was more commonly observed in both synovium and cartilage (22 of the 28 specimens), was especially prominent at cartilage erosion sites, and most of the positive specimens demonstrated extracellular enzyme. By contrast, collagenase 3 was observed less frequently (7/28 specimens) and was produced by relatively few chondrocytes and synovial cells, this usually being much less than that observed for chondrocytes of osteoarthritic cartilage. These observations suggest different regulatory mechanisms for the production of collagenases 1 and 3 in the rheumatoid lesion, and demonstrate that the distribution and production of collagenase 1 are far more prevalent than those for collagenase 3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9487253     DOI: 10.1093/rheumatology/37.1.64

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  17 in total

1.  Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis.

Authors:  P K Petrow; D Wernicke; C Schulze Westhoff; K M Hummel; R Bräuer; J Kriegsmann; E Gromnica-Ihle; R E Gay; S Gay
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

2.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

3.  RelA is required for IL-1beta stimulation of Matrix Metalloproteinase-1 expression in chondrocytes.

Authors:  L Raymond; S Eck; E Hays; I Tomek; S Kantor; M Vincenti
Journal:  Osteoarthritis Cartilage       Date:  2006-11-13       Impact factor: 6.576

4.  Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.

Authors:  Shilpi Agarwal; Ramnath Misra; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

5.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

6.  Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.

Authors:  P J Koshy; N Henderson; C Logan; P F Life; T E Cawston; A D Rowan
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

7.  Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.

Authors:  Mary-Clare Miller; Hugh B Manning; Abhilash Jain; Linda Troeberg; Jayesh Dudhia; David Essex; Ann Sandison; Motoharu Seiki; Jagdeep Nanchahal; Hideaki Nagase; Yoshifumi Itoh
Journal:  Arthritis Rheum       Date:  2009-03

8.  Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis.

Authors:  Jin Su; Jiangtian Yu; Tingting Ren; Wei Zhang; Yuanqiang Zhang; Xinping Liu; Tiezheng Sun; Houshan Lu; Keiji Miyazawa; Libo Yao
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

9.  Regulation of inflammatory response in human chondrocytes by lentiviral mediated RNA interference against S100A10.

Authors:  Changzhi Song; Xiaoye Zhou; Qirong Dong; Rengen Fan; Guangzhou Wu; Biao Ji; Qingbing Meng; Minqian Zheng
Journal:  Inflamm Res       Date:  2012-07-14       Impact factor: 4.575

Review 10.  Cartilage homeostasis in health and rheumatic diseases.

Authors:  Mary B Goldring; Kenneth B Marcu
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.